These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22908200)

  • 1. A brain on cannabinoids: the role of dopamine release in reward seeking.
    Oleson EB; Cheer JF
    Cold Spring Harb Perspect Med; 2012 Aug; 2(8):. PubMed ID: 22908200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction.
    Peters KZ; Oleson EB; Cheer JF
    Cold Spring Harb Perspect Med; 2021 Jan; 11(1):. PubMed ID: 31964646
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabinoid modulation of drug reward and the implications of marijuana legalization.
    Covey DP; Wenzel JM; Cheer JF
    Brain Res; 2015 Dec; 1628(Pt A):233-43. PubMed ID: 25463025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using dopamine research to generate rational cannabinoid drug policy.
    Loewinger GC; Oleson EB; Cheer JF
    Drug Test Anal; 2013 Jan; 5(1):22-6. PubMed ID: 22991092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.
    Panagis G; Vlachou S; Nomikos GG
    Curr Drug Abuse Rev; 2008 Nov; 1(3):350-74. PubMed ID: 19630731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance.
    Everett TJ; Gomez DM; Hamilton LR; Oleson EB
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110031. PubMed ID: 32663486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
.
    Spanagel R
    Dialogues Clin Neurosci; 2020 Sep; 22(3):241-250. PubMed ID: 33162767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
    Cooper ZD; Haney M
    Addict Biol; 2008 Jun; 13(2):188-95. PubMed ID: 18279497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward.
    Flores Á; Maldonado R; Berrendero F
    Biol Psychiatry; 2014 Mar; 75(6):499-507. PubMed ID: 23896204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats.
    Cadoni C; Simola N; Espa E; Fenu S; Di Chiara G
    Addict Biol; 2015 Jan; 20(1):132-42. PubMed ID: 23957273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic changes induced by cannabinoid drugs and cannabis use disorder.
    Augustin SM; Lovinger DM
    Neurobiol Dis; 2022 Jun; 167():105670. PubMed ID: 35219856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.
    Kesner AJ; Lovinger DM
    J Neurochem; 2021 Jun; 157(5):1674-1696. PubMed ID: 33891706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.
    Lawn W; Freeman TP; Pope RA; Joye A; Harvey L; Hindocha C; Mokrysz C; Moss A; Wall MB; Bloomfield MA; Das RK; Morgan CJ; Nutt DJ; Curran HV
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3537-52. PubMed ID: 27585792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory effects of cannabinoids on brain neurotransmission.
    Cohen K; Weizman A; Weinstein A
    Eur J Neurosci; 2019 Aug; 50(3):2322-2345. PubMed ID: 30882962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM; Koethe D
    Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system.
    Hoffman AF; Lupica CR
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23209160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of cannabinoid dependence in animals.
    Maldonado R
    Pharmacol Ther; 2002 Aug; 95(2):153-64. PubMed ID: 12182962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid signaling system and brain reward: emphasis on dopamine.
    Gardner EL
    Pharmacol Biochem Behav; 2005 Jun; 81(2):263-84. PubMed ID: 15936806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210.
    Serrano A; Vadas E; Ferrer B; Bilbao A; Granado N; Suárez J; Pavon FJ; Moratalla R; Rodríguez de Fonseca F
    Psychopharmacology (Berl); 2021 Feb; 238(2):551-557. PubMed ID: 33410990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana: harder than thought?
    Wickelgren I
    Science; 1997 Jun; 276(5321):1967-8. PubMed ID: 9221496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.